BDBM238955 US9403831, 46
SMILES: CC(=O)N1CCN(Cc2ccc(cc2)-c2cnc(nc2)N2CCCC(Cn3nnc4ncc(nc34)-c3cnn(C)c3)C2)CC1
InChI Key: InChIKey=PYFMYJADIZTTGB-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatocyte growth factor receptor (Homo sapiens (Human)) | BDBM238955 (US9403831, 46) | PDB MMDB KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | 25 |
KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY; HANDOK INC. US Patent | Assay Description The c-Met kinase inhibitory activity was analyzed using dissociation enhanced lanthanide fluoro-immunoassay (DELFIA, Perkin Elmer), which is a kind o... | US Patent US9403831 (2016) BindingDB Entry DOI: 10.7270/Q2TD9W7H | |||||||||||
More data for this Ligand-Target Pair |